InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Cohen Joshua B, Chairman & CEO. Director active across 1 companies, notably Amylyx Pharmaceuticals, Inc.. Cumulatively, 3 disclosures have been logged. The latest transaction was filed on 5 May 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations3 total
€117,434334,520 shares@ €0.35110.0080% mcap100.0% of flow
Common Stock
SEC:0000899243-22-017083:0·
04,870 shares0
Common Stock
SEC:0000899243-22-001518·
04,870 shares0
Common Stock
SEC:0000899243-22-001518:0·
3 of 3 declarations
About Cohen Joshua B
Joshua B. Cohen is the Co-Chief Executive Officer of Amylyx Pharmaceuticals, Inc. He shares responsibility for the strategic direction of the company, overseeing operations and development initiatives. Cohen brings expertise in the pharmaceutical sector, contributing to innovation and growth at Amylyx.
